Dex Media Announces First Quarter 2017 Financial Results
Broad Range of Clinical Data Evaluating Celgene Therapies to Be Presented at American Society of Clinical Oncology (ASCO)
X-Chem and Vertex Enter into Multi-Target Genetic Disease Collaboration
What they are, where they came from, where they're going--and how to evaluate them.
Falling oil prices buffet some CEFs, but many have turned out strong returns so far this year.